高安动脉炎的进展：亚太地区视角
Advances in Takayasu arteritis: An Asia Pacific perspective.
作者信息
Danda Debashish, Manikuppam Prathyusha, Tian Xinping, Harigai Masayoshi
机构信息
Department of Clinical Immunology and Rheumatology, Christian Medical College and Hospital, Vellore, India.
Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College Hospital (PUMCH), Beijing, China.
出版信息
Front Med (Lausanne). 2022 Aug 15;9:952972. doi: 10.3389/fmed.2022.952972. eCollection 2022.
Abstract
Takayasu Arteritis (TA) is a rare form of chronic granulomatous large vessel vasculitis that is more common in Asia compared to other parts of the world. There have been several developments in the field of Takayasu arteritis in relation to genetics, classification, clinical features, imaging, disease activity assessment and management and much of these works have been done in the Asia Pacific region. We will be discussing selected few in the current review.
摘要
高安动脉炎（TA）是一种罕见的慢性肉芽肿性大血管血管炎，与世界其他地区相比，在亚洲更为常见。在高安动脉炎领域，在遗传学、分类、临床特征、影像学、疾病活动评估和管理方面有了一些进展，其中许多工作是在亚太地区完成的。在本次综述中，我们将讨论其中的一些精选内容。
相似文献
1
Advances in Takayasu arteritis: An Asia Pacific perspective.高安动脉炎的进展：亚太地区视角
Front Med (Lausanne). 2022 Aug 15;9:952972. doi: 10.3389/fmed.2022.952972. eCollection 2022.
2
HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.巨细胞动脉炎中的 HLA-B52 等位基因可能预示着弥漫性大血管血管炎的形成：一项回顾性研究。
Arthritis Res Ther. 2021 Sep 13;23(1):238. doi: 10.1186/s13075-021-02618-4.
3
[Large vessel vasculitis: giant cell arteritis and Takayasu arteritis].[大血管血管炎：巨细胞动脉炎和高安动脉炎]
Rev Med Suisse. 2007 Apr 25;3(108):1056-60, 1062-3.
4
Current Diagnosis and Management of Takayasu Arteritis.高安动脉炎的当前诊断与管理
Int Heart J. 2023;64(4):519-534. doi: 10.1536/ihj.23-195.
5
The Severity of Takayasu Arteritis Is Associated with the HLA-B52 Allele in Japanese Patients.在日本患者中，高安动脉炎的严重程度与HLA - B52等位基因相关。
Tohoku J Exp Med. 2016 May;239(1):67-72. doi: 10.1620/tjem.239.67.
6
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review.大血管血管炎结局评估工具的测量特性：系统文献回顾。
J Rheumatol. 2023 Jun;50(6):789-798. doi: 10.3899/jrheum.220149. Epub 2022 Nov 1.
7
Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis.血清胎球蛋白 A 水平作为 Takayasu 动脉炎和肉芽肿性多血管炎患者疾病活动的新型生物标志物。
Clin Rheumatol. 2022 Apr;41(4):1169-1176. doi: 10.1007/s10067-021-06020-y. Epub 2022 Jan 11.
8
New human leukocyte antigen risk allele in Japanese patients with Takayasu arteritis.日本大动脉炎患者中的新人类白细胞抗原风险等位基因。
Circ J. 2012;76(7):1697-702. doi: 10.1253/circj.cj-12-0089. Epub 2012 May 16.
9
Association of clinical manifestations with HLA-B alleles in Takayasu arteritis.高安动脉炎的临床表现与HLA - B等位基因的关联
Int J Cardiol. 1998 Oct 1;66 Suppl 1:S121-6. doi: 10.1016/s0167-5273(98)00159-4.
10
Epidemiology of Takayasu arteritis.大动脉炎的流行病学
Presse Med. 2017 Jul-Aug;46(7-8 Pt 2):e197-e203. doi: 10.1016/j.lpm.2017.05.034. Epub 2017 Jul 26.
引用本文的文献
1
Arteritic Anterior Ischemic Optic Neuropathy in Takayasu Arteritis: An Ominous Systemic Sign?高安动脉炎所致动脉炎性前部缺血性视神经病变：一种不祥的全身征象？
J Ophthalmic Vis Res. 2025 Jul 30;20. doi: 10.18502/jovr.v20.14442. eCollection 2025.
2
Positron Emission Tomography in Takayasu Arteritis: A Review Including Patterns of Vascular Involvement Across Modalities and Regions.正电子发射断层扫描在大动脉炎中的应用：综述，包括跨模态和区域的血管受累模式
J Clin Med. 2025 Apr 24;14(9):2939. doi: 10.3390/jcm14092939.
3
Positron Emission Tomography Imaging of the Adaptive Immune System in Cardiovascular Diseases.心血管疾病中适应性免疫系统的正电子发射断层扫描成像
Chem Biomed Imaging. 2025 Mar 19;3(4):209-224. doi: 10.1021/cbmi.4c00117. eCollection 2025 Apr 28.
4
Functional and Practical Insights Into the Genetic Basis of Takayasu Arteritis.对大动脉炎遗传基础的功能及实践见解
ACR Open Rheumatol. 2025 Jan;7(1):e11766. doi: 10.1002/acr2.11766. Epub 2024 Nov 12.
5
CD8 cell-derived granzyme B may be a predictor for coronary artery involvement and MACE in Takayasu arteritis patients.CD8细胞衍生的颗粒酶B可能是大动脉炎患者冠状动脉受累和主要不良心血管事件的一个预测指标。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae095.
6
Carotidynia as the First Manifestation of Takayasu Arteritis: Report of Two Cases and a Brief Review of Literature.以颈动脉痛为首发表现的大动脉炎：2例报告及文献简要回顾
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4873-4876. doi: 10.1007/s12070-024-04938-8. Epub 2024 Aug 1.
7
Clinical Characteristics and Outcomes of Aortic Arch Emergencies: Takayasu Disease, Fibromuscular Dysplasia, and Aortic Arch Pathologies: A Retrospective Study and Review of the Literature.主动脉弓急症的临床特征与预后：大动脉炎、纤维肌性发育异常及主动脉弓病变：一项回顾性研究及文献综述
Biomedicines. 2023 Aug 6;11(8):2207. doi: 10.3390/biomedicines11082207.
8
Common Autoantibody among Takayasu Arteritis and Ulcerative Colitis: A Possible Pathophysiology That Includes Gut-Vessel Connection in Vascular Inflammation.高安动脉炎和溃疡性结肠炎中的常见自身抗体：一种可能的病理生理学机制，包括血管炎症中肠道与血管的联系。
JMA J. 2023 Jul 14;6(3):265-273. doi: 10.31662/jmaj.2023-0038. Epub 2023 May 29.
9
Refractory Takayasu's Arteritis with Severe Coronary Involvement-Case Report and Literature Review.难治性高安动脉炎伴严重冠状动脉受累——病例报告及文献综述
J Clin Med. 2023 Jun 29;12(13):4394. doi: 10.3390/jcm12134394.
10
Clinical and vascular lesion characteristics of the patients with takayasu arteritis manifested firstly as acute myocardial infarction at onset.以急性心肌梗死为首发表现的大动脉炎患者的临床及血管病变特征
Heliyon. 2023 Jan 20;9(2):e13099. doi: 10.1016/j.heliyon.2023.e13099. eCollection 2023 Feb.
本文引用的文献
1
Takayasu's arteritis: a review of the literature and the role of endovascular treatment.高安动脉炎：文献综述及血管内治疗的作用
AsiaIntervention. 2018 Sep 20;4(2):117-125. doi: 10.4244/AIJ-D-16-00013. eCollection 2018 Sep.
2
Global epidemiology of vasculitis.血管炎的全球流行病学。
Nat Rev Rheumatol. 2022 Jan;18(1):22-34. doi: 10.1038/s41584-021-00718-8. Epub 2021 Dec 1.
3
Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour and Welfare for intractable vasculitis.建立 Takayasu 动脉炎的临床缓解标准和治疗目标算法框架：由日本厚生劳动省难治性血管炎研究委员会专家小组进行的 Delphi 研究结果。
Mod Rheumatol. 2022 Aug 20;32(5):930-937. doi: 10.1093/mr/roab081.
4
Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab.大动脉炎的生物治疗：肿瘤坏死因子抑制剂与托珠单抗的对比研究。
Semin Arthritis Rheum. 2021 Dec;51(6):1224-1229. doi: 10.1016/j.semarthrit.2021.09.010. Epub 2021 Oct 9.
5
CD8 T lymphocyte is a main source of interferon-gamma production in Takayasu's arteritis.CD8 T 淋巴细胞是 Takayasu 动脉炎中干扰素-γ产生的主要来源。
Sci Rep. 2021 Aug 24;11(1):17111. doi: 10.1038/s41598-021-96632-w.
6
PET in Takayasu arteritis: onwards and upwards towards a future of robust multimodality disease activity assessment?正电子发射断层扫描（PET）在高安动脉炎中的应用：朝着强大的多模态疾病活动评估的未来不断前进？
Rheumatology (Oxford). 2022 Apr 18;61(SI):SI4-SI5. doi: 10.1093/rheumatology/keab644.
7
Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study.托法替布对比甲氨蝶呤治疗大动脉炎的疗效和安全性：一项前瞻性观察研究。
Ann Rheum Dis. 2022 Jan;81(1):117-123. doi: 10.1136/annrheumdis-2021-220832. Epub 2021 Aug 6.
8
Application progress of multiple imaging modalities in Takayasu arteritis.多种影像学模态在大动脉炎中的应用进展。
Int J Cardiovasc Imaging. 2021 Dec;37(12):3591-3601. doi: 10.1007/s10554-021-02348-3. Epub 2021 Jul 21.
9
A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritis.IL12B 而非 LILRA3 区域中的一个易感基因座与 Takayasu 动脉炎的血管损伤相关。
Sci Rep. 2021 Jul 1;11(1):13667. doi: 10.1038/s41598-021-93213-9.
10
A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET/CT: a Chinese cohort study.基于18F-FDG-PET/CT评估大动脉炎疾病活动度的新型模型：一项中国队列研究
Rheumatology (Oxford). 2022 Apr 18;61(SI):SI14-SI22. doi: 10.1093/rheumatology/keab487.
Zotero 插件